Back to search
FDAFDA · Food and drugs·Recall number D-1096-2019

PAPAVERINE-PHENTOLAMINE-PGE1 23-0.96MG-19.2MCG/ML INJECTABLE, (a) 5ml, (b) 6.5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330

Published April 17, 2019 · Recall initiated: February 21, 2019

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.

What to do

Voluntary: Firm initiated · Telephone

Recall details

Manufacturer
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy
Distributor
Dispensed in Oregon
Lot
Lot: (a) 22102018@31, (b) 09112018@33, distributed between 09-01-2018 to 02-20-2019.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card